# Energetically equivalent structural transitions in the Rad17–Rad9–Hus1–Rad1–Rhino complex underlie the sequential progression from activation through maintenance to inactivation of the ATR-dependent DNA damage response

**Authors:** Yasunori Fukumoto, Ryuzaburo Yuki, Yasumitsu Ogra

PMC · DOI: 10.1093/nar/gkag093 · 2026-02-16

## TL;DR

The study reveals how structural changes in a DNA damage response complex help regulate the activation, maintenance, and inactivation of the ATR-dependent DNA damage response.

## Contribution

The study identifies energetically equivalent structural transitions in the Rad17–Rad9–Hus1–Rad1–Rhino complex that underlie the progression of the ATR-dependent DNA damage response.

## Key findings

- Rhino bridges two 9–1–1 complexes through conserved KYxxL+ motifs, enabling polymerization.
- Rad9's C-terminal tail competes with Rhino and Rad17, leading to checkpoint inactivation.
- Binding free energies of intermediate complexes are comparable, supporting energetically equivalent transitions.

## Abstract

Activation of the ATR-dependent DNA damage response (ATR-DDR) is well characterized; however, the molecular mechanisms underlying its maintenance and inactivation remain largely elusive. Rhino is the least understood component of ATR-DDR. Structural modeling and binding free energy calculations revealed structural remodeling involving Rad17, Rad9–Hus1–Rad1 (9–1–1), and Rhino during ATR-DDR progression. Biochemical and computational analyses revealed the competitive binding of Rad17 and Rhino to the 9–1–1 complex, suggesting a structural transition from the Rad17–9–1–1 complex to the Rhino–9–1–1 complex. The presence of two conserved KYxxL+ motifs in Rhino suggests that it bridges the two 9–1–1 complexes. This enables the polymerization of multiple 9–1–1 complexes through Rhino and explains the long-standing discrepancy between the conventional model and experimental observations of Rad17 and Rad9 foci. Furthermore, structural analysis of the Rad9 C-terminal tail revealed its ability to compete with both Rhino and Rad17, leading to disassembly of the checkpoint complex and providing a mechanism for checkpoint inactivation. Quantum chemical calculations revealed comparable binding free energies for intermediate complexes. These observations suggest that the Rad17–9–1–1–Rhino complex undergoes energetically equivalent structural transitions, providing a mechanistic basis for the sequential progression of ATR-DDR.

Graphical Abstract

## Linked entities

- **Genes:** RAD17 (RAD17 checkpoint clamp loader component) [NCBI Gene 5884], RAD9A (RAD9 checkpoint clamp component A) [NCBI Gene 5883], HUS1 (HUS1 checkpoint clamp component) [NCBI Gene 3364], RAD1 (RAD1 checkpoint DNA exonuclease) [NCBI Gene 5810], RHNO1 (RAD9-HUS1-RAD1 interacting nuclear orphan 1) [NCBI Gene 83695], ATR (ATR checkpoint kinase) [NCBI Gene 545]
- **Proteins:** RAD17 (RAD17 checkpoint clamp loader component), RAD9A (RAD9 checkpoint clamp component A), HUS1 (HUS1 checkpoint clamp component), RAD1 (RAD1 checkpoint DNA exonuclease), RHNO1 (RAD9-HUS1-RAD1 interacting nuclear orphan 1), ATR (ATR checkpoint kinase)

## Full-text entities

- **Genes:** RAD1 (RAD1 checkpoint DNA exonuclease) [NCBI Gene 5810] {aka HRAD1, REC1}, KRT13 (keratin 13) [NCBI Gene 3860] {aka CK13, K13, WSN2}, RAD24 (Rad24p) [NCBI Gene 856920], FEN1 (flap structure-specific endonuclease 1) [NCBI Gene 2237] {aka FEN-1, MF1, RAD2}, RAD17 (Rad17p) [NCBI Gene 854550], RAD17 (RAD17 checkpoint clamp loader component) [NCBI Gene 5884] {aka CCYC, HRAD17, R24L, RAD17SP, RAD24}, RAD9A (RAD9 checkpoint clamp component A) [NCBI Gene 5883] {aka RAD9}, RAD9 (chromatin-binding protein RAD9) [NCBI Gene 851803], ATR (ATR checkpoint kinase) [NCBI Gene 545] {aka FCTCS, FRP1, MEC1, SCKL, SCKL1}, DDC1 (Ddc1p) [NCBI Gene 855907], RAD1 (ssDNA endodeoxyribonuclease RAD1) [NCBI Gene 856085] {aka LPB9, RAD12}, MEC3 (Mec3p) [NCBI Gene 850995] {aka PIP3, PSO9}, HUS1 (HUS1 checkpoint clamp component) [NCBI Gene 3364] {aka hHUS1}, H3P16 (H3 histone pseudogene 16) [NCBI Gene 644914] {aka H3.6, H3F3AP6, p21}, RHNO1 (RAD9-HUS1-RAD1 interacting nuclear orphan 1) [NCBI Gene 83695] {aka C12orf32, HKMT1188, RHINO}, MAMLD1 (mastermind like domain containing 1) [NCBI Gene 10046] {aka CG1, CXorf6, F18, HYSP2}, PCNA (proliferating cell nuclear antigen) [NCBI Gene 5111] {aka ATLD2}
- **Diseases:** cancer (MESH:D009369), CRS (MESH:D003398), APBS (MESH:D018489)
- **Chemicals:** carbon (MESH:D002244), polyacrylamide (MESH:C016679), Triton X-100 (MESH:D017830), pTM (MESH:D010646), ATPgammaS (MESH:C022571), salt (MESH:D012492), NaCl (MESH:D012965), MgCl2 (MESH:D015636), NaOH (MESH:D012972), BS (MESH:D001895), SDS (MESH:D012967), leucine (MESH:D007930), water (MESH:D014867), thymidine (MESH:D013936), Cl- (MESH:D002713), Na+ (MESH:D012964), glycerol (MESH:D005990), HEPES (MESH:D006531), disulfide (MESH:D004220), 3G65 (-), H (MESH:D006859), KCl (MESH:D011189), PBS (MESH:D007854), agarose (MESH:D012685), sucrose (MESH:D013395), ATP (MESH:D000255)
- **Species:** Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Mus musculus (house mouse, species) [taxon 10090], Caenorhabditis elegans (species) [taxon 6239], Schizosaccharomyces pombe (fission yeast, species) [taxon 4896], Diasemopsis sp. M (species) [taxon 141377], Homo sapiens (human, species) [taxon 9606], Arabidopsis thaliana (mouse-ear cress, species) [taxon 3702], Drosophila melanogaster (fruit fly, species) [taxon 7227], Gallus gallus (bantam, species) [taxon 9031], Xenopus laevis (African clawed frog, species) [taxon 8355]
- **Mutations:** F366A, F365, L94A, F366, K359, A-I, L364, F365A, F96A, F96S, F91, K360, R362A, leucine at position +5, arginine at position +3, K85A, L364A, F91A, thymidine for 24, K90, L94S, F159A, K13, F159, K13E, K360A, P15S, R84A, L16S, F91S, lysine at position +1, I158A, K359A, R84, K90E, R362, F96, L17S, F18S
- **Cell lines:** T88 — Mus musculus (Mouse), Factor-dependent cell line (CVCL_5369), COS-1 — Chlorocebus aethiops (Green monkey), Transformed cell line (CVCL_0223), Sp — Sus scrofa (Pig), Porcine lymphoma, Cancer cell line (CVCL_ZJ36)

## Figures

12 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12907562/full.md

---
Source: https://tomesphere.com/paper/PMC12907562